Boston Scientific (BSX) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 2 082 | 1 833 | 2 784 | 2 800 | 3 620 | 3 616 | ||
Changes by years, y/y, % | -14% | -12% | +52% | +1% | +29% | +8.4% |
Boston Scientific. EBITDA US GAAP, bln rub
Boston Scientific. EBITDA US GAAP, changes, %
Boston Scientific. EBITDA US GAAP, sum by quarters, bln rub
Boston Scientific (BSX) EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA, bln rub | ? | 744.0 | 798.0 | 801.0 | 1 016 | 1 001 | 3 616 | |
Changes by years, y/y, % | +15% | +13% | +22% | +29% | +35% | |||
Changes by quarters, q/q, % | -5% | +7% | +0% | +27% | -1% |